✦ LIBER ✦

Tolerability of statin-fibrate and statin-niacin combination therapy in dyslipidemic patients at high risk for cardiovascular events

✍ Scribed by Taha H Taher; Vladimir Dzavik; Ethel M Reteff; Glen J Pearson; Bonnie L Woloschuk; Gordon A Francis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High Cardiovascular Risk in Patients Wit

✍ Guido Lastra Gonzalez; Camila Margarita Manrique; James R. Sowers 📂 Article 📅 2006 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 425 KB

Statin Therapy in the Reduction of Cardi

✍ Raju, Manjunath G.; Pachika, Ajay; Punnam, Sujeeth R.; Gardiner, Joseph C.; Shis 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Management of mixed dyslipidemia in pati

✍ Sergio Fazio 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 1007 KB

Statin and Aspirin Therapy for the Preve

✍ Jacob A. Udell; Benjamin M. Scirica; Eugene Braunwald; Itamar Raz; Ph. Gabriel S 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB

Comparative effectiveness of statin plus

✍ Hae Sun Suh; Joel W. Hay; Kathleen A. Johnson; Jason N. Doctor 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

Therapeutic practice patterns related to

✍ Toth, Peter P.; Foody, JoAnne M.; Tomassini, Joanne E.; Sajjan, Shiva G.; Ramey, 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 917 KB